GFACX
Price
$72.61
Change
+$0.04 (+0.06%)
Updated
Aug 13 closing price
Net Assets
329.32B
VAFAX
Price
$32.46
Change
-$0.18 (-0.55%)
Updated
Aug 13 closing price
Net Assets
18.08B
Interact to see
Advertisement

GFACX vs VAFAX

Header iconGFACX vs VAFAX Comparison
Open Charts GFACX vs VAFAXBanner chart's image
American Funds Growth Fund of Amer C
Price$72.61
Change+$0.04 (+0.06%)
VolumeN/A
Net Assets329.32B
Invesco American Franchise A
Price$32.46
Change-$0.18 (-0.55%)
VolumeN/A
Net Assets18.08B
GFACX vs VAFAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. VAFAX commentary
Aug 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and VAFAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 329B vs. VAFAX (18.1B). GFACX (0.00) and VAFAX (0.00) have matching dividends . GFACX was incepted earlier than VAFAX: GFACX (24 years) vs VAFAX (20 years). GFACX (1.36) is less costly to investors than VAFAX (0.96). VAFAX is a more actively managed with annual turnover of: 51.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than VAFAX: GFACX (250) vs VAFAX (1000). VAFAX annual gain was more profitable for investors over the last year : 22.11 vs. GFACX (15.18). GFACX return over 5 years is better than : 34.71 vs. VAFAX (20.58).
GFACXVAFAXGFACX / VAFAX
Total Expense Ratio1.360.96142%
Annual Report Gross Expense Ratio1.360.96142%
Fund Existence24 years20 years-
Gain YTD13.88011.210124%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets329B18.1B1,818%
Annual Yield % from dividends0.000.00-
Returns for 1 year15.1822.1169%
Returns for 3 years36.8258.3763%
Returns for 5 years34.7120.58169%
Returns for 10 years69.3387.3779%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OKTA90.981.65
+1.85%
Okta
UE19.630.06
+0.31%
Urban Edge Properties
EVOK4.93-0.06
-1.20%
Evoke Pharma, Inc.
CPAC6.22-0.08
-1.27%
Cementos Pacasmayo SAA
PLRX1.60-0.08
-4.76%
Pliant Therapeutics